<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36805409</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>328</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies.</ArticleTitle><Pagination><StartPage>199074</StartPage><MedlinePgn>199074</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199074</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2023.199074</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(23)00036-9</ELocationID><Abstract><AbstractText>Hand, foot and mouth disease (HFMD) is caused by a variety of serotypes in species A of the Enterovirus genus, including recently re-emerged Coxsackievirus A2 (CV-A2), CV-A4 and CV-A5. For development of diagnostic reagents, for surveillance, and the development of multivalent vaccines against HFMD, the antigenicity of HFMD-associated enteroviruses warrants investigation. The purified virions of CV-A4 were inoculated into Balb/c mice and hybridomas were obtained secreting monoclonal antibodies (mAbs) directed against CV-A4 and cross-reacting with other closely related species A enteroviruses. The mAbs were characterized by ELISA, Western blotting and in vitro neutralizing assays. The majority of mAbs was non-neutralizing, with only 2% of the mAbs neutralizing CV-A4 specifically. Most of mAbs bound to linear VP1 epitopes of CV-A4. Interestingly, four types of mAbs were obtained which bound specifically to CV-A4 or were broadly to CV-A4/-A2, CV-A4/-A5 and CV-A4/-A2/-A5, respectively. Mapping with overlapping or single-amino-acid mutant peptides revealed that the four types of mAbs all bound to the first 15 amino acids at the N-terminus of the VP1. This region of picornaviruses is functionally important as it is involved in uncoating and releasing of viral RNA into the cytosol. The binding footprints of four type mAbs are composed of conserved and variable residues and are different from each other. The newly discovered broadly cross-reactive mAbs reflect the high homology of CV-A4/ CV-A2/CV-A5. The results also demonstrate that it is possible and beneficial to develop the diagnostic reagents to detect rapidly the main pathogens of enteroviruses associated with HFMD cause by CV-A4/CV-A2/CV-A5.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yu-Xuan</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wei-Ping</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhen-Ni</ForeName><Initials>ZN</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Shi-Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng-Jun</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Sheng-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ze-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co. Ltd., No.1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430207, China. Electronic address: shenshuo0227@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Broadly binding activity</Keyword><Keyword MajorTopicYN="N">Coxsackievirus A2/A4/A5</Keyword><Keyword MajorTopicYN="N">Epitopes</Keyword><Keyword MajorTopicYN="N">Monoclonal antibodies</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>9</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36805409</ArticleId><ArticleId IdType="pmc">PMC10194160</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2023.199074</ArticleId><ArticleId IdType="pii">S0168-1702(23)00036-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong H., Lu Y., Zhang Y., Mu S., Wang N., Du P., Zhi X., Wen X., Wang X., Sun S., Zhang Y., Guo H. A heat-induced mutation on VP1 of foot-and-mouth disease virus serotype o enhanced capsid stability and immunogenicity. J. Virol. 2021;95(16) doi: 10.1128/JVI.00177-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00177-21</ArticleId><ArticleId IdType="pmc">PMC8312871</ArticleId><ArticleId IdType="pubmed">34011545</ArticleId></ArticleIdList></Reference><Reference><Citation>Faleye T.O., Adewumi M.O., Adeniji J.A. Defining the enterovirus diversity landscape of a fecal sample: a methodological challenge? Viruses. 2016;8(1):18. doi: 10.3390/v8010018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010018</ArticleId><ArticleId IdType="pmc">PMC4728578</ArticleId><ArticleId IdType="pubmed">26771630</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Wan Z., Li Y., Hu Y., Jin X., Zhang C. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol. Sin. 2020;35(1):21&#x2013;33. doi: 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F., Wang Y.P., Mao Q.Y., Yao X., Liu S., Li F.X., Zhu F.C., Yang J.Y., Liang Z.L., Lu F.M., Wang J.Z. Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virol. J. 2012;9:26. doi: 10.1186/1743-422X-9-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-26</ArticleId><ArticleId IdType="pmc">PMC3292509</ArticleId><ArticleId IdType="pubmed">22264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoa-Tran T.N., Nguyen A.T., Dao A.T.H., Kataoka C., Ta H.T.T., Nguyen H.T.V., Takemura T., Nguyen T.T.T., Vu H.M., Nguyen T.T.H., Shimizu H. Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012-2017: endemic circulation and emergence of new HFMD-causing lineages. Arch. Virol. 2020;165(4):823&#x2013;834. doi: 10.1007/s00705-020-04536-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04536-3</ArticleId><ArticleId IdType="pubmed">32008121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G., Jin W.P., Yang Z.H., Lv S.Y., Wu J., Yu Y.T., Meng S.L., Guo J., Wang Z.J., Shen S. Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain. Vaccine. 2022;40(33):4716&#x2013;4725. doi: 10.1016/j.vaccine.2022.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.06.021</ArticleId><ArticleId IdType="pubmed">35760737</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Huang Y.H., Tsai H.P., Kuo P.H., Wang S.M., Liu C.C., Wang J.R. A selective bottleneck shapes the evolutionary mutant spectra of Enterovirus A71 during viral dissemination in humans. J. Virol. 2017;91(23) doi: 10.1128/JVI.01062-17. e01062&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01062-17</ArticleId><ArticleId IdType="pmc">PMC5686718</ArticleId><ArticleId IdType="pubmed">28931688</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin W.P., Lu J., Zhang X.Y., Wu J., Wei Z.N., Mai J.Y., Qian S.S., Yu Y.T., Meng S.L., Wang Z.J., Shen S. Efficacy of coxsackievirus A5 vaccine candidates in an actively immunized mouse model. J. Virol. 2021;95(6) doi: 10.1128/JVI.01743-20. e01743&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01743-20</ArticleId><ArticleId IdType="pmc">PMC8094937</ArticleId><ArticleId IdType="pubmed">33408178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim X.F., Jia Q., Chow V.T.K., Kwang J. Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein. J. Virol. Methods. 2013;188(1&#x2013;2):76&#x2013;82. doi: 10.1016/j.jviromet.2012.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.11.038</ArticleId><ArticleId IdType="pubmed">23219932</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Ren M., Chen S., Nie T., Cui J., Ran L., Li Z., Chang Z. Pathogen spectrum of hand, foot, and mouth disease based on laboratory surveillance - China, 2018. China. CDC. Wkly. 2020;2(11):167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393163</ArticleId><ArticleId IdType="pubmed">34594617</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchs A., Azevedo L.S., Souza E.V., Medeiros R.S., Souza Y.F.V.P., Teixeira D.L.F., Carneiro T.F.O., Alencar G.M.F., Morais F.L.S.L., Pinto D.F.A., Okay T.S., Yamamoto L., Morais V.D.S., Ara&#xfa;jo E.L.L., Leal E., Costa A.C.D. Coxsackievirus A6 strains causing an outbreak of hand-foot-and-mouth disease in Northeastern Brazil in 2018. Rev. Inst. Med. Trop. Sao. Paulo. 2022;64:e16. doi: 10.1590/S1678-9946202264016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946202264016</ArticleId><ArticleId IdType="pmc">PMC8862545</ArticleId><ArticleId IdType="pubmed">35195198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandary M.B., Poh C.L. Changes in the EV-A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10(6):320. doi: 10.1590/S1678-9946202264016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946202264016</ArticleId><ArticleId IdType="pmc">PMC6024729</ArticleId><ArticleId IdType="pubmed">29895721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.Y., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert. Rev. Vaccines. 2016;15(5):599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-L&#xf3;pez N., Mu&#xf1;oz-Almagro C., Launes C., Navascu&#xe9;s A., Imaz-P&#xe9;rez M., Reina J., Romero M.P., Calvo C., Ruiz-Garc&#xed;a M., Megias G., Valencia-Ramos J., Otero A., Cabrerizo M. Surveillance for enteroviruses associated with hand, foot, and mouth disease, and other mucocutaneous symptoms in Spain, 2006-2020. Viruses. 2021;13(5):781. doi: 10.3390/v13050781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050781</ArticleId><ArticleId IdType="pmc">PMC8146579</ArticleId><ArticleId IdType="pubmed">33924875</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick J.L. Enteroviruses. Sci Am. 1959;200(2):88&#x2013;97. doi: 10.1038/scientificamerican0259-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/scientificamerican0259-88</ArticleId><ArticleId IdType="pubmed">13624742</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X.D., Tong Y., Wei Z.N., Wang L., Mai J.Y., Wu Y., Luo Z.Y., Li S., Li M., Wang S., Wei S., Gong W., Zhang W., Hu X., Huang J., Shi J., Yang G., Meng S., Wang Z., Guan X., Shen S. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang. China. Sci. Rep. 2020;10(1):20909. doi: 10.1038/s41598-020-77768-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77768-7</ArticleId><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="pubmed">33262488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan L.N.T, Khanh T.H, Hong N.T.T, Van H.M.T, Nhu L.N.T, Ny N.T.H, Nguyet L.A, Thanh T.T, Anh N.T, Hang V.T.T, Qui P.T, Viet H.L, Tung T.H, Ha D.Q, Tuan H.M, Thwaites G., Chau N.V.V, Thwaites L., Hung N.T., van, Doorn H.R, Tan L.V. Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015&#x2013;2018. PLoS. Negl. Trop. Dis. 2020;14(8) doi: 10.1371/journal.pntd.0008544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008544</ArticleId><ArticleId IdType="pmc">PMC7451980</ArticleId><ArticleId IdType="pubmed">32804980</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 1999;73(3):1941&#x2013;1948. doi: 10.1128/JVI.73.3.1941-1948.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.3.1941-1948.1999</ArticleId><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Lim P.Y., Perera R., Cardosa J., Suksatu A., Kuhn R.J., Rossmann M.G. Neutralizing antibodies can initiate genome release from human enterovirus 71. Proc. Natl. Acad. Sci. USA. 2014;111(6):2134&#x2013;2139. doi: 10.1073/pnas.1320624111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320624111</ArticleId><ArticleId IdType="pmc">PMC3926013</ArticleId><ArticleId IdType="pubmed">24469789</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian S.S., Wei Z.N., Jin W.P., Wu J., Zhou Y.P., Meng S.L., Guo J., Wang Z.J., Shen S. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model. Emerg. Microbes. Infect. 2021;10(1):763&#x2013;773. doi: 10.1080/22221751.2021.1906755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1906755</ArticleId><ArticleId IdType="pmc">PMC8079124</ArticleId><ArticleId IdType="pubmed">33739899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Wang X., Hu Z., Gao Q., Sun Y., Li X., Porta C., Walter T.S., Gilbert R.J., Zhao Y., Axford D., Williams M., McAuley K., Rowlands D.J., Yin W., Wang J., Stuart D.I., Rao Z., Fry E.E. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 2013;4:1929. doi: 10.1038/ncomms2889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2889</ArticleId><ArticleId IdType="pmc">PMC3709478</ArticleId><ArticleId IdType="pubmed">23728514</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., Johansson B., Wahren B., S&#xe4;llberg M. Molecular basis for serological cross-reactivity between enteroviruses. Clin. Diagn. Lab. Immunol. 1994;1(3):336&#x2013;341. doi: 10.1128/cdli.1.3.336-341.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.1.3.336-341.1994</ArticleId><ArticleId IdType="pmc">PMC368258</ArticleId><ArticleId IdType="pubmed">7496972</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., S&#xe4;llberg M. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 1995;2(3):385&#x2013;386. doi: 10.1128/cdli.2.3.385-386.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.2.3.385-386.1995</ArticleId><ArticleId IdType="pmc">PMC170165</ArticleId><ArticleId IdType="pubmed">7545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Standardization Administration of China, 2018. Laboratory animal-guideline for ethical review of animal welfare. https://openstd.samr.gov.cn/bzgk/gb/index. (Accessed 13 January 2023).</Citation></Reference><Reference><Citation>Simmonds P., Gorbalenya A.E., Harvala H., Hovi T., Knowles N.J., Lindberg A.M., Oberste M.S., Palmenberg A.C., Reuter G., Skern T., Tapparel C., Wolthers K.C., Woo P.C.Y., Zell R. Recommendations for the nomenclature of enteroviruses and rhinoviruses. Arch. Virol. 2020;165(3):793&#x2013;797. doi: 10.1007/s00705-019-04520-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04520-6</ArticleId><ArticleId IdType="pmc">PMC7024059</ArticleId><ArticleId IdType="pubmed">31980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.X., Wei Z.N., An H.H., Wu J., Shen S. Analysis of biochemical characteristics and immunogenicity of coxsackievirus A4. Chin. J. Virol. 2022;38(03):581&#x2013;590. doi: 10.13242/j.cnki.bingduxuebao.004065. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="doi">10.13242/j.cnki.bingduxuebao.004065</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabelsi A., Grattard F., Nejmeddine M., Aouni M., Bourlet T., Pozzetto B. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. J. Clin. Microbiol. 1995;33(9):2454&#x2013;2457. doi: 10.1128/jcm.33.9.2454-2457.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.33.9.2454-2457.1995</ArticleId><ArticleId IdType="pmc">PMC228436</ArticleId><ArticleId IdType="pubmed">7494045</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., Cowling B.J., Varma J.K., Farrar J.J., Leung G.M., Yu H. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet. Infect. Dis. 2014;14(4):308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C.Z., Wen D.N., Zhou J.G., Luo J.F., Wang Z.J., Shen S., Li H.D., Chen X.Q. Molecular epidemiological analysis of enteroviruses associated with hand, foot and mouth disease in Wuhan in 2018. Chin. J. Biologicals. 2020;33(11):1262&#x2013;1269. doi: 10.13200/j.cnki.cjb.003196. (in Chinese)</Citation><ArticleIdList><ArticleId IdType="doi">10.13200/j.cnki.cjb.003196</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Ding J., Cao J., Huang Q., Hong C., Yang B. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J. Med. Virol. 2015;87(6):954&#x2013;960. doi: 10.1002/jmv.24151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24151</ArticleId><ArticleId IdType="pubmed">25754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef G.E., Brownm I.N., Mowbray J.F. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology. 1987;28(3):163&#x2013;170. doi: 10.1159/000150012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150012</ArticleId><ArticleId IdType="pubmed">2836335</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef G.E., Mann G.F., Brown I.N., Mowbray J.F. Clinical and research application of an enterovirus group-reactive monoclonal antibody. Intervirology. 1987;28(4):199&#x2013;205. doi: 10.1159/000150017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150017</ArticleId><ArticleId IdType="pubmed">2835329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y.T., Hu G., Luo Z.Y., Lu J., Wang Z.J., Meng S.L., Shen S. Preparation, purification and identification of virus-like particles of Coxsackievirus A2. Chin. J. Biologicals. 2021;34(07):782&#x2013;787. doi: 10.13200/j.cnki.cjb.003389. (in Chinese)</Citation><ArticleIdList><ArticleId IdType="doi">10.13200/j.cnki.cjb.003389</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y.T., Luo Z.Y., Jin W.P., Mai J.Y., Qian S.S., Lu J., Wei Z.N., Meng S.L., Wang Z.J., Guan X.H., Tong Y.Q., Shen S. Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China. 2021. BMC. Med. Genomics. 2021;14(1):279. doi: 10.1186/s12920-021-01107-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-021-01107-6</ArticleId><ArticleId IdType="pmc">PMC8611921</ArticleId><ArticleId IdType="pubmed">34819054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Jiang B., Xu M., Dai X., Purdy M.A., Meng J. Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection. Virus. Res. 2014;189:248&#x2013;253. doi: 10.1016/j.virusres.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.06.003</ArticleId><ArticleId IdType="pmc">PMC4698801</ArticleId><ArticleId IdType="pubmed">24952304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Zhang G., Liu S., Chen X., Peng R., Dai L., Qu X., Li S., Song H., Gao Z., Yuan P., Liu Z., Li C., Shang Z., Li Y., Zhang M., Qi J., Wang H., Du N., Wu Y., Bi Y., Gao S., Shi Y., Yan J., Zhang Y., Xie Z., Wei W., Gao G.F. Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B. Cell. 2019;177(6):1&#x2013;13. doi: 10.1016/j.cell.2019.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.035</ArticleId><ArticleId IdType="pmc">PMC7111318</ArticleId><ArticleId IdType="pubmed">31104841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Van, Tan L., Luo K., Liao Q., Wang L., Qiu Q., Zou G., Liu P., Anh N.T., Hong N.T.T., He M., Wei X., Yu S., Lam T.T., Cui J., van, Doorn H.R., Yu H. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in Southern China. Virol. Sin. 2021;36(1):61&#x2013;74. doi: 10.1007/s12250-020-00266-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00266-7</ArticleId><ArticleId IdType="pmc">PMC7385209</ArticleId><ArticleId IdType="pubmed">32725479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>